There are multiple theories on why patients with COVID-19 are at an increased risk for CVD. As part of a comprehensive work-up for patients with COVID-19, various lab tests may be warranted, especially those relating to coagulation such as PT, aPTT, D-dimer, fibrinogen, ADAMTS13, and APOE.